Speaker
Description
There is sufficient information in vitro and in vivo that indicates that AT1 receptor (part of the blood pressure regulated system Renin-Angiotensin) is overexpressed in malignant tumor. The losartan is one of the most studied antagonist of this receptor, for that reason, this study evaluated the fluoro-alkyl losartan-derivatives (
- H. Zhang, et al., Cell, 2015. 161: p. 833–844.
- J. Kujawski, et al., Molecules, 2015. 20: p. 11875-11890.
- Álvarez-Ginartea Y. M., et al., Journal of Steroid Biochemistry and Molecular Biology, 2013. 138: p. 348–358.